MedPath

湖南金圃医药科技有限公司

Ownership
-
Established
2022-07-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Loxoprofen Sodium Cataplasms

Product Name
洛索洛芬钠凝胶贴膏
Approval Number
国药准字H20253455
Approval Date
Feb 25, 2025
NMPA

Ebastine Oral Solution

Product Name
依巴斯汀口服溶液
Approval Number
国药准字H20249219
Approval Date
Oct 29, 2024
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath